INSM stock was sold by a variety of institutional investors in the last quarter, including Barclays PLC, Janus Henderson Group PLC, Alliancebernstein L.P., Rice Hall James & Associates LLC, Baker BROS. Advisors LP, Hudson Bay Capital Management LP, GSA Capital Partners LLP, and C WorldWide Group Holding A S. Company insiders that have sold Insmed company stock in the last year include Alfred Altomari, Christine A Pellizzari, John Soriano, Melvin Md Sharoky, Orlov S Nicole Schaeffer, and William Lewis.
View insider buying and selling activity for Insmed or view top insider-selling stocks.